vimarsana.com
Home
Live Updates
Adolore Biotherapeutics, Inc.: Adolore Biotherapeutics Enter
Adolore Biotherapeutics, Inc.: Adolore Biotherapeutics Enter
Adolore Biotherapeutics, Inc.: Adolore Biotherapeutics Enters into Exclusive License Agreement with University of Pittsburgh for Patents Protecting Non-Toxic Replication-Defective HSV Vectors for Efficient Gene Delivery Applications and Complementing Cell
Company developing next generation, disease-modifying, non-opioid analgesic gene therapies for the treatment of chronic painDELRAY BEACH, FL / ACCESSWIRE / May 23, 2023 / Adolore Biotherapeutics, Inc.
Related Keywords
Jenene Thomas ,
Gewinn Nur ,
University Of Pittsburg ,
Adolore Biotherapeutics Inc ,
University Of Pittsburgh ,
Adolore Biotherapeutics Inc View ,
Toxic Herpes Simplex Virus Vectors ,
Efficient Gene Delivery Applications ,
Complementing Cells ,
Herpes Simplex Virus ,
Carbonic Anhydrase Like Analgesic Peptides ,
Orphan Drug ,
Disease Modifying Anti Pain ,
Inc View ,
Adolore ,
Iotherapeutics ,
Centers ,
Exclusive ,
License ,
Agreement ,
University ,
Pittsburgh ,
Patents ,
Protecting ,
Toxic ,
Replication ,
Defective ,
Sectors ,
Efficient ,
Gene ,
Delivery ,
Applications ,
Complementing ,